Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocompromised patients:: randomised pilot study (Combistrat Trial)

被引：0
|
作者：
Caillot, D.
Thiebaut, A.
Herbrecht, R.
Pigneux, A.
de Botton, S.
Attal, M.
Bernard, F.
Larche, J.
Alfandari, S.
Monchecourt, F.
Mahi, L.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70821-X
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [1] Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies -: A randomized pilot study (Combistrat trial)
    Caillot, Denis
    Thiebaut, Anne
    Herbrecht, Raoul
    de Botton, Stephane
    Pigneux, Arnaud
    Bernard, Frederic
    Larche, Jerome
    Monchecourt, Francoise
    Alfandari, Serge
    Mahi, Lamine
    [J]. CANCER, 2007, 110 (12) : 2740 - 2746
  • [2] Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis
    Elanjikal, Z
    Sörensen, J
    Schmidt, H
    Dupuis, W
    Tintelnot, K
    Jautzke, G
    Klingebiel, T
    Lehrnbecher, T
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (07) : 653 - 656
  • [3] Standard dosing regimen of liposomal amphotericin B is as effective as a high-loading dose for patients with invasive aspergillosis:: AmBiLoad trial
    Loss-Floerl, Cornelia
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (06) : 929 - 932
  • [4] Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis
    Pouvaret, A.
    Dureault, A.
    Garcia-Hermoso, D.
    Serris, A.
    Cohen, J. F.
    Guery, R.
    Lanternier, F.
    Lortholary, O.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [5] Caspofungin and liposomal amphotericin B used singly and in combination for the treatment of experimental cerebral aspergillosis
    Ullmann, I.
    Strahm, R.
    Leib, S. L.
    Zimmerli, S.
    [J]. MYCOSES, 2009, 52 : 122 - 123
  • [6] Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats
    Ruijgrok, EJ
    Vulto, AG
    Van Etten, EWM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) : 89 - 95
  • [7] Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
    Kontoyiannis, DP
    Hachem, R
    Lewis, RE
    Rivero, GA
    Torres, HA
    Thornby, J
    Champlin, R
    Kantarjian, H
    Bodey, GP
    Raad, II
    [J]. CANCER, 2003, 98 (02) : 292 - 299
  • [8] Aerosolized Liposomal Amphotericin B: A Potential Prophylaxis of Invasive Pulmonary Aspergillosis in Immunocompromised Patients
    Kamalaporn, Harutai
    Leung, Kitty
    Nagel, Mark
    Kittanakom, Saranya
    Calvieri, Battista
    Reithmeier, Reinhart A. F.
    Coates, Allan L.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 (06) : 574 - 580
  • [9] Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
    Hachem, Ray Y.
    Boktour, Maha R.
    Hanna, Hend A.
    Husni, Rola N.
    Torres, Harrys A.
    Afif, Claude
    Kontoyiannis, Dimitrios P.
    Raad, Issam I.
    [J]. CANCER, 2008, 112 (06) : 1282 - 1287
  • [10] Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study
    Cordonnier, Catherine
    Mohty, Mohamad
    Faucher, Catherine
    Pautas, Cecile
    Robin, Marie
    Vey, Norbert
    Monchecourt, Francoise
    Mahi, Lamine
    Ribaud, Patricia
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) : 135 - 141
12345